The average one-year price target for Inovio Pharmaceuticals (NasdaqCM:INO) has been revised to $8.73 / share. This is an increase of 12.14% from the prior estimate of $7.79 dated January 11, 2026.
The average one-year price target for Inovio Pharmaceuticals (NasdaqCM:INO) has been revised to $8.73 / share. This is an increase of 12.14% from the prior estimate of $7.79 dated January 11, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results